Versant Capital Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $45.3K | Hold |
|
|||||
|
2025
Q2 | $29.1K | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $505 | Sell |
|
|||||
|
2023
Q1 | $1.54K | Hold |
|
|||||
|
2022
Q4 | $1.4K | Sell |
|
|||||
|
2022
Q3 | $2K | Buy |
|
|||||
|
2022
Q2 | $1K | Hold |
|
|||||
|
2022
Q1 | $1K | Sell |
|
|||||
|
2021
Q4 | $2K | Sell |
|
|||||
|
2021
Q3 | $15K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $0 | Hold |
|
|||||
|
2019
Q3 | $0 | Buy |
|